Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
MNKD - Mannkind Corp
-1.70(-29.77%)9:00:00 PM 3/1/2021
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Although volume ZSCore is at high level but it has returned from prior high level and momentum has slowed down.
  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio-19.2
PEG Ratio-0.8
P/S (ttm)20.7
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %7%
Held by Institutions %30%
1 Day Vol Adjusted Return-2.5
1 Month Vol Adjusted Return0.7
3 Month Vol Adjusted Return4.2
6 Month Vol Adjusted Return16.1
20 Days SMA Price ZScore-1.8
50 Days SMA Price ZScore-0.2
12 -26 Days PPO7.3
1 Month Average Short Volume Ratio42.7
1 Day Volume Change ZScore2.8
1 Month Daily Vol12.1
Related Topics
leak data

Related Topics


Stock news